Skip to Content

Posts tagged with "Press Coverage"

  • Cancer

    A Glioblastoma Vaccine? Not Yet.

    If you get your biomedical breaking news from the British press, you will have heard all about a very promising vaccine treatment for glioblastoma. (“Remarkably promising” – BBC. “Could add years” – The Guardian. And there’s the Daily Mail (naturally), The Independent, and more). That would be good news, b… Read More
  • Cancer

    Cancer Sequencing Hype And Reality

    This piece in Science says something that needs to be said louder and more publicly. If you live in the US, you’ve surely seen various cancer treatment centers talking about their personalized therapy plans, and especially how they’ll tailor things to your DNA sequence and so on. You would get the impression that we have… Read More
  • Business and Markets

    On Lies, and Liars

    ]\Today’s topic is “lies”. We will start with the cases of Elizabeth Holmes and Ramesh (“Sunny”) Balwani, of Theranos. As the world knows, Theranos was not what it was represented to be – John Carreyrou of the Wall Street Journal and his extraordinary demolition job on them showed that beyond doubt. But remember… Read More
  • Press Coverage

    Gotta Be a Conclusion In Here Somewhere

    A couple of years ago, I wrote about how far too much of human nutrition research was unfit to draw conclusions from. This new story does nothing to make a person more confident in the field: it’s a detailed look at the lab of Brian Wansink at Cornell, where he hold an endowed chair. He’s… Read More
  • Alzheimer's Disease

    More Rough Alzheimer’s News

    Man, Alzheimer’s. That’s my reaction to yesterday’s news in the field. Merck started things off with news of their last-ditch attempt to see if their beta-secretase (BACE) inhibitor verubecestat (MK-8931) could be useful. I’ve been writing about that one for a while – here’s 2012, when they announced that the com… Read More
  • Press Coverage

    Where Does the News Hype Come From?

    From Chris Chambers on Twitter (of Cardiff Univ.) come some very important points about press coverage of scientific results. I often make references here to misleading and inaccurate headlines and stories in the popular press – as a scientist, it’s hard to take, seeing research results mangled in the only venues that most people will… Read More
  • Cancer

    A Hard Look At Liquid Biopsies

    This new paper has generated a lot of headlines (Science news writeup here). It reports work on the long-sought “liquid biopsy” idea for cancer screening, the use of circulating biomarkers to detect tumors via a blood test. The idea has obvious appeal, so much appeal that many news stories over the years have gotten well… Read More
  • Alzheimer's Disease

    Neurotrope: A Shameful PR Stunt

    There was some Alzheimer’s news the other day, but it wasn’t actually about Alzheimer’s. Not very much. It was more about hype, press releases, and a grievous lack of understanding of statistics. Via @AndyBiotech and @biotechtoreador on Twitter, I came across this release about an announcement from a small company called Neurot… Read More
  • Drug Prices

    Those Australian Students And Their Daraprim

    OK, enough people have emailed me the press coverage of the students in Sydney making daraprim, which is the drug that Martin Shkreli’s former firm has famously jacked up the price of. From what I can see, a lot of the news stories on this are missing the point. Daraprim is not hard to make in… Read More
  • Alzheimer's Disease

    The Limits of Big Data

    I fear that mentioning the phrase “Big Data” in the first sentence of a blog post will make half the potential readers suddenly remember that they have podiatrist appointments or something. But that’s the only way to approach this article at Wired. After all, the title is “The Cure For Cancer is Data – Mountains of… Read More
123...